Tech Company Financing Transactions

Alcresta Therapeutics Funding Round

Alcresta Therapeutics secured a $5 million funding round on 9/30/2012. Backers included Bessemer Venture Partners, Frazier Healthcare Partners and Third Rock Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

1 Newton Executive Park 100
Newton, MA 02462
USA

Phone

(617) 431-3600

Website

www.alcresta.com

Email Address

[email protected]

Overview

Alcresta's enzyme expertise and proprietary platform enables novel products for those with compromised pancreatic output and malabsorption.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Daniel Orlando

        

Chief Financial Officer

Tasos Konidaris

        

Chief Scientific Officer

Eric First

        

VP - General Counsel

William Scheinler

        

VP - Sales

Darbi James

        

Browse more venture capital transactions:

Prev: 9/30/2012: Nanoscale venture capital transaction
Next: 9/30/2012: Assure Space venture capital transaction

Share this article

About Our VC Transactions Data

We record every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary